Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 88 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH/NIAMS
Grant: P50AR070588
NIH/NIAMS
Grant: P30AR69632
National Institutes of Health
Grant: 1S10RR027050-01A1
Becton Dickinson LSR II Analytical Flow Cytometer
National Institutes of Health
Grant: 5K01AR070291-05
Functional Studies of the IL-7/IL-7R Pathway in Alopecia Areata
National Institutes of Health
Grant: 5P30AR069632-04
Columbia University Skin Disease Resource-Based Center (epiCURE)
National Institutes of Health
Grant: 1S10OD020056-01
BD Biosciences Influx
National Institutes of Health
Grant: 3P50AR070588-01S1
Alopecia Areata Center for Research Translation (AACORT)
NCRR NIH HHS
Grant: S10 RR027050
NIAMS NIH HHS
Grant: P30 AR069632
NIAMS NIH HHS
Grant: K01 AR070291
NIH HHS
Grant: S10 OD020056
FWCI
12.02
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
Additional file 1 of Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter